Phase I Study Panitumumab Plus Chemoradiotherapy and Induction Chemotherapy in Patients With Locally Advanced Squamous Cell Cancer of the Head and Neck.
Phase of Trial: Phase I
Latest Information Update: 04 Mar 2017
At a glance
- Drugs Panitumumab (Primary) ; Carboplatin; Cisplatin; Docetaxel; Fluorouracil; Paclitaxel
- Indications Head and neck cancer
- Focus Adverse reactions
- 27 Feb 2017 Status changed from active, no longer recruiting to completed.
- 06 Mar 2012 Planned end date changed from 1 Apr 2010 to 1 Dec 2013 as reported by ClinicalTrials.gov.
- 09 Oct 2009 Planned end date changed from Apr 2009 to Apr 2010 as reported by ClinicalTrials.gov.